Published in Ann Allergy Asthma Immunol on October 05, 2011
Bronchial asthma: is personalized therapy on the horizon? Allergo J Int (2014) 0.75
Is there an association between postural balance and pulmonary function in adults with asthma? Clinics (Sao Paulo) (2013) 0.75
High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med (2005) 7.20
Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial. Lancet (2012) 5.82
Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells. Immunity (2010) 3.64
Delays in starting morning operating lists: an analysis of more than 20,000 cases in 22 German hospitals. Dtsch Arztebl Int (2013) 3.14
Efficacy of a new once-daily long-acting inhaled beta2-agonist indacaterol versus twice-daily formoterol in COPD. Thorax (2010) 2.79
Helicobacter pylori infection prevents allergic asthma in mouse models through the induction of regulatory T cells. J Clin Invest (2011) 2.77
Allergen-induced asthmatic responses modified by a GATA3-specific DNAzyme. N Engl J Med (2015) 2.44
Neutrophil chemotactic activity of sputum from patients with COPD: role of interleukin 8 and leukotriene B4. Chest (2003) 2.04
Protection from graft-versus-host disease by HIV-1 envelope protein gp120-mediated activation of human CD4+CD25+ regulatory T cells. Blood (2009) 1.78
Effector CD8+ T cells mediate inflammation and airway hyper-responsiveness. Nat Med (2004) 1.71
DC-derived IL-18 drives Treg differentiation, murine Helicobacter pylori-specific immune tolerance, and asthma protection. J Clin Invest (2012) 1.68
Assessment of lymph node tuberculosis in northern Germany: a clinical review. Chest (2002) 1.66
Naturally occurring lung CD4(+)CD25(+) T cell regulation of airway allergic responses depends on IL-10 induction of TGF-beta. J Immunol (2007) 1.63
The enhancement or prevention of airway hyperresponsiveness during reinfection with respiratory syncytial virus is critically dependent on the age at first infection and IL-13 production. J Immunol (2005) 1.56
New horizons in early stage COPD--improving knowledge, detection and treatment. Respir Med (2011) 1.56
Staging small cell lung cancer: Veterans Administration Lung Study Group versus International Association for the Study of Lung Cancer--what limits limited disease? Lung Cancer (2002) 1.53
Production of serotonin by tryptophan hydroxylase 1 and release via platelets contribute to allergic airway inflammation. Am J Respir Crit Care Med (2013) 1.49
Effectiveness of omalizumab in patients 50 years and older with severe persistent allergic asthma. Ann Allergy Asthma Immunol (2010) 1.47
Overall asthma control: the relationship between current control and future risk. J Allergy Clin Immunol (2010) 1.41
Interleukin-1 receptor antagonist attenuates airway hyperresponsiveness following exposure to ozone. Am J Respir Cell Mol Biol (2004) 1.36
QVA149 demonstrates superior bronchodilation compared with indacaterol or placebo in patients with chronic obstructive pulmonary disease. Thorax (2010) 1.36
Lung function in idiopathic pulmonary fibrosis--extended analyses of the IFIGENIA trial. Respir Res (2009) 1.34
Invasive and noninvasive methods for studying pulmonary function in mice. Respir Res (2007) 1.34
Lung Transplantation in Germany Since the Introduction of the Lung Allocation Score. Dtsch Arztebl Int (2017) 1.34
Outcome measures in chronic obstructive pulmonary disease (COPD): strengths and limitations. Respir Res (2010) 1.31
Contribution of antigen-primed CD8+ T cells to the development of airway hyperresponsiveness and inflammation is associated with IL-13. J Immunol (2004) 1.30
Specific and redundant roles for NFAT transcription factors in the expression of mast cell-derived cytokines. J Immunol (2006) 1.29
Specific IgE against Staphylococcus aureus enterotoxins: an independent risk factor for asthma. J Allergy Clin Immunol (2012) 1.28
V gamma 4+ gamma delta T cells regulate airway hyperreactivity to methacholine in ovalbumin-sensitized and challenged mice. J Immunol (2003) 1.25
Helicobacter pylori γ-glutamyl transpeptidase and vacuolating cytotoxin promote gastric persistence and immune tolerance. Proc Natl Acad Sci U S A (2013) 1.23
Mast cells are crucial for early inflammation, migration of Langerhans cells, and CTL responses following topical application of TLR7 ligand in mice. Blood (2007) 1.23
Selective suppression of neutrophil accumulation in ongoing pulmonary inflammation by systemic inhibition of p38 mitogen-activated protein kinase. J Immunol (2002) 1.22
Moving from the Oslerian paradigm to the post-genomic era: are asthma and COPD outdated terms? Thorax (2013) 1.20
Leukotriene B4 receptor-1 is essential for allergen-mediated recruitment of CD8+ T cells and airway hyperresponsiveness. J Immunol (2005) 1.18
Inhibition of cAMP degradation improves regulatory T cell-mediated suppression. J Immunol (2009) 1.13
IL-22 is produced by innate lymphoid cells and limits inflammation in allergic airway disease. PLoS One (2011) 1.13
MDCT assessment of airway wall thickness in COPD patients using a new method: correlations with pulmonary function tests. Eur Radiol (2008) 1.11
The use of omalizumab in the treatment of severe allergic asthma: A clinical experience update. Respir Med (2009) 1.11
Sputum biomarker profiles in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) and association between pulmonary function. Cytokine (2010) 1.09
Characterization of c-kit expression in small cell lung cancer: prognostic and therapeutic implications. Clin Cancer Res (2003) 1.09
Ozone exposure in vivo and formation of biologically active oxysterols in the lung. J Pharmacol Exp Ther (2004) 1.08
Treatment of non-small cell lung cancer patients with the trifunctional monoclonal antibody catumaxomab (anti-EpCAM x anti-CD3): a phase I study. Cancer Immunol Immunother (2007) 1.08
Guideline-based survey of outpatient COPD management by pulmonary specialists in Germany. Int J Chron Obstruct Pulmon Dis (2012) 1.04
Efficacy of a fixed combination of ciclesonide and formoterol: the EXCITED-study. Respir Med (2011) 1.03
Complement activation is critical to airway hyperresponsiveness after acute ozone exposure. Am J Respir Crit Care Med (2003) 1.03
Long-term repeatability of induced sputum cells and inflammatory markers in stable, moderately severe COPD. Chest (2003) 1.03
Soluble triggering receptor expressed on myeloid cells 1 is released in patients with stable chronic obstructive pulmonary disease. Clin Dev Immunol (2007) 1.02
Importance of myeloid dendritic cells in persistent airway disease after repeated allergen exposure. Am J Respir Crit Care Med (2005) 1.02
Bimosiamose, an inhaled small-molecule pan-selectin antagonist, attenuates late asthmatic reactions following allergen challenge in mild asthmatics: a randomized, double-blind, placebo-controlled clinical cross-over-trial. Pulm Pharmacol Ther (2005) 1.01
Transcriptional and post-transcriptional regulation of iNOS expression in human chondrocytes. Biochem Pharmacol (2009) 1.00
The prognostic impact of blood group-related antigen Lewis Y and the ABH blood groups in resected non-small cell lung cancer. Tumour Biol (2008) 1.00
Surfactant protein D regulates airway function and allergic inflammation through modulation of macrophage function. Am J Respir Crit Care Med (2003) 1.00
Clinical application of a simple questionnaire for the differentiation of asthma and chronic obstructive pulmonary disease. Respir Med (2004) 0.99
Evidence that CD8+ dendritic cells enable the development of gammadelta T cells that modulate airway hyperresponsiveness. J Immunol (2008) 0.98
Tissue microarrays are reliable tools for the clinicopathological characterization of lung cancer tissue. Anticancer Res (2009) 0.96
Mismatched antigen prepares gamma delta T cells for suppression of airway hyperresponsiveness. J Immunol (2005) 0.96
The tick salivary protein sialostatin L inhibits the Th9-derived production of the asthma-promoting cytokine IL-9 and is effective in the prevention of experimental asthma. J Immunol (2012) 0.96
Against all odds: anti-IgE for intrinsic asthma? Thorax (2013) 0.95
Effect of microbial heat shock proteins on airway inflammation and hyperresponsiveness. J Immunol (2002) 0.94
Advances in the understanding of mast cell function. Br J Haematol (2008) 0.94
Antigen specificity is not required for modulation of lung allergic responses by naturally occurring regulatory T cells. J Immunol (2009) 0.94
Induction and maintenance of airway responsiveness to allergen challenge are determined at the age of initial sensitization. J Immunol (2004) 0.94
Characterization of the interstitial lung and peripheral blood T cell receptor repertoire in cigarette smokers. Am J Respir Cell Mol Biol (2004) 0.93
Vaccine-induced CD8+ T cell-dependent suppression of airway hyperresponsiveness and inflammation. J Immunol (2009) 0.93
Tc9 cells, a new subset of CD8(+) T cells, support Th2-mediated airway inflammation. Eur J Immunol (2013) 0.92
TLR3 but not TLR7/8 ligand induces allergic sensitization to inhaled allergen. J Immunol (2012) 0.92
Overall asthma control achieved with budesonide/formoterol maintenance and reliever therapy for patients on different treatment steps. Respir Res (2011) 0.91
Alteration of airway neuropeptide expression and development of airway hyperresponsiveness following respiratory syncytial virus infection. Am J Physiol Lung Cell Mol Physiol (2004) 0.91
Efficacy of Tiotropium + Olodaterol in Patients with Chronic Obstructive Pulmonary Disease by Initial Disease Severity and Treatment Intensity: A Post Hoc Analysis. Adv Ther (2015) 0.91
The role of virus-specific immunoglobulin E in airway hyperresponsiveness. Am J Respir Crit Care Med (2004) 0.90
Severe and uncontrolled adult asthma is associated with vitamin D insufficiency and deficiency. Respir Res (2013) 0.89
Omalizumab and the risk of malignancy: results from a pooled analysis. J Allergy Clin Immunol (2012) 0.89
Respiratory syncytial virus-induced airway hyperresponsiveness is independent of IL-13 compared with that induced by allergen. J Allergy Clin Immunol (2003) 0.89
c-kit expression in adenocarcinomas of the lung. Tumour Biol (2005) 0.87
Subclinical left ventricular dysfunction by echocardiographic speckle-tracking strain analysis relates to outcome in sarcoidosis. Eur J Heart Fail (2014) 0.87
Genetic variation determines mast cell functions in experimental asthma. J Immunol (2011) 0.87
An open-label, prospective phase I/II study evaluating the immunogenicity and safety of a ras peptide vaccine plus GM-CSF in patients with non-small cell lung cancer. Lung Cancer (2007) 0.87
Mast cells induce migration of dendritic cells in a murine model of acute allergic airway disease. Int Arch Allergy Immunol (2009) 0.86
Pulmonary dysfunction in non-cirrhotic patients with chronic viral hepatitis. Eur J Intern Med (2002) 0.86
Allergic airway hyperresponsiveness-enhancing gammadelta T cells develop in normal untreated mice and fail to produce IL-4/13, unlike Th2 and NKT cells. J Immunol (2009) 0.86
Increased glutathione disulfide and nitrosothiols in sputum supernatant of patients with stable COPD. Chest (2004) 0.86
Mast cells in allergic asthma and beyond. Yonsei Med J (2010) 0.85
PAR-2 inhibition reverses experimental pulmonary hypertension. Circ Res (2012) 0.85
Neutrophilic inflammation in induced sputum of patients with idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis (2003) 0.84
Helicobacter urease-induced activation of the TLR2/NLRP3/IL-18 axis protects against asthma. J Clin Invest (2015) 0.83
Underdiagnosis and overdiagnosis of asthma in the morbidly obese. Respir Med (2013) 0.83
Synthesis and preliminary evaluation of (R,R)(S,S) 5-(2-(2-[4-(2-[(18)F]fluoroethoxy)phenyl]-1-methylethylamino)-1-hydroxyethyl)-benzene-1,3-diol ([(18)F]FEFE) for the in vivo visualisation and quantification of the beta2-adrenergic receptor status in lung. Bioorg Med Chem Lett (2003) 0.82
Anticholinergics in the treatment of chronic obstructive pulmonary disease. Respiration (2002) 0.82
Improvement in quality of life with omalizumab in patients with severe allergic asthma. Curr Med Res Opin (2006) 0.82
Murine genetic deficiency of neuronal nitric oxide synthase (nNOS(-/-) ) and interstitial cells of Cajal (W/W(v) ): Implications for achalasia? J Gastroenterol Hepatol (2014) 0.82